This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

5 Biotech Stocks Under $5 Blasting Off

Biosante Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Biosante Pharmaceuticals (BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. This stock is trading up 9.8% to $1.55 in recent trading.

Today's Range: $1.39-$1.58

52-Week Range: $1.21-$17.58

Volume: 660,000

Three-Month Average Volume: 772,327

>>5 Stocks Under $10 Set to Soar

From a technical perspective, BPAX is ripping higher here right off some near-term support at $1.35 with decent volume. This stock has been downtrending badly for the last six months, with shares falling from $4.62 to its recent low of $1.21 a share. During that move, shares of BPAX have consistently made lower highs and lower lows, which is bearish technical price action. That said, BPAX has now started to rebound off that $1.21 low, and it's setting up to trigger a near-term breakout trade.

Traders should now look for long-biased trades in BPAX if it can manage to break out above some near-term overhead resistance levels at $1.50 to $1.62 with high volume. Look for a sustained move or close above those levels with volume that's near or above 772,327 shares. If that breakout hits soon, then look for BPAX to re-test and possibly take out its next major overhead resistance levels at $1.96 to $2.25.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BPAX $55.05 -1.24%
PATH $0.00 0.00%
ABIO $0.75 -2.60%
GERN $3.63 29.00%
AAPL $126.52 -1.60%

Markets

DOW 18,120.66 +23.76 0.13%
S&P 500 2,101.15 +2.62 0.12%
NASDAQ 4,981.7590 +14.6180 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs